What is the appropriate dosage of Bactrim DS (trimethoprim‑sulfamethoxazole) for an adult with an ESBL‑producing urinary tract infection?

Bactrim DS Dosage for ESBL UTI

For an adult with an ESBL-producing urinary tract infection, use Bactrim DS (trimethoprim-sulfamethoxazole 160/800 mg) one tablet twice daily for 14 days if the organism is susceptible to TMP/SMX. 1

Critical Context: ESBL and Treatment Selection

ESBL-producing organisms are classified as complicated UTIs by definition 2. However, TMP/SMX can be effective if susceptibility testing confirms the organism is sensitive, despite ESBL production 3, 4. The key is waiting for culture results before committing to this regimen.

Dosing Specifics

Standard dosing:

• Bactrim DS (double strength): 1 tablet every 12 hours
• Regular Bactrim: 2 tablets every 12 hours
• Duration: 14 days for complicated UTI 2, 1

This differs from uncomplicated pyelonephritis where TMP/SMX is given for 14 days 2, but the complicated nature of ESBL infection warrants the full 14-day course.

Renal Dose Adjustment

Adjust for kidney function 1:

• CrCl >30 mL/min: Standard dose
• CrCl 15-30 mL/min: Half the usual dose
• CrCl <15 mL/min: Do not use

Important Caveats

When NOT to Use TMP/SMX

Do not use empirically for ESBL UTIs. The 2024 EAU guidelines do not recommend TMP/SMX for empirical treatment of complicated UTIs 2. ESBL organisms frequently carry co-resistance to TMP/SMX 3.

Initial empirical therapy should be:

• Intravenous carbapenem (meropenem 1g TID, imipenem 0.5g TID) 2
• Or newer agents (ceftolozane/tazobactam, ceftazidime/avibactam) 2
• Then de-escalate to oral TMP/SMX only if susceptibility confirmed

Safety Concerns

Monitor closely for adverse effects, particularly in older adults:

• Acute kidney injury risk increases 72% compared to amoxicillin 5
• Hyperkalaemia risk increases 127% 5
• Risk amplifies dramatically in patients on:
  • ACE inhibitors or ARBs
  • Spironolactone (18 additional hyperkalaemia cases per 1000 treated) 5

Check baseline and follow-up:

• Serum creatinine
• Serum potassium (especially if on RAS blockers)

Alternative Oral Options for ESBL

If TMP/SMX is not suitable or organism is resistant, consider these oral alternatives with high ESBL activity 3:

• Pivmecillinam (if available): 400 mg TID for 10 days (>95% ESBL sensitivity)
• Fosfomycin: Single 3g dose for cystitis only (>95% ESBL sensitivity)
• Nitrofurantoin: 100 mg BID for 5-7 days for cystitis only (>93% E. coli ESBL sensitivity, but poor for Klebsiella)

Do not use these for pyelonephritis or febrile UTI - insufficient tissue penetration 2.

Clinical Algorithm

1. Obtain urine culture before starting antibiotics
2. Start empirical IV therapy (carbapenem or broad-spectrum agent) for febrile/complicated ESBL UTI
3. Review susceptibilities at 48-72 hours
4. If TMP/SMX susceptible: Switch to Bactrim DS 1 tablet BID for total 14 days
5. If resistant: Continue IV therapy or use alternative oral agent based on susceptibilities
6. Monitor renal function and potassium at baseline and during therapy